Evidence map›Paper›PMID 28424560›Full record

ArticleBreast cancer (Dove Medical Press)2017

An exploratory study of host polymorphisms in genes that clinically characterize breast cancer tumors and pretreatment cognitive performance in breast cancer survivors.

Theresa A Koleck, Catherine M Bender, Beth Z Clark, Christopher M Ryan, Puja Ghotkar, Adam Brufsky, Priscilla F McAuliffe, Priya Rastogi, Susan M Sereika, Yvette P Conley

Open access · goldAbstract read
In one paragraph

Article in Breast cancer (Dove Medical Press), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 2 pooled it
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 2 syntheses or guidelines pooled it, 23 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Article
  6. The biology of SCUBE.Journal of biomedical science · 2023
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

Theresa A KoleckSchool of Nursing, University of Pittsburgh, Pittsburgh, PA.
Catherine M BenderSchool of Nursing, University of Pittsburgh, Pittsburgh, PA.
Beth Z ClarkDivision of Gynecologic Pathology, Magee-Womens Hospital of University of Pittsburgh Medical Center (UPMC).
Christopher M RyanDepartment of Psychiatry, University of Pittsburgh, Pittsburgh, PA.
Puja GhotkarSchool of Nursing, University of Pittsburgh, Pittsburgh, PA.
Adam BrufskySchool of Medicine.
Priscilla F McAuliffeSchool of Medicine.
Priya RastogiSchool of Medicine.
Susan M SereikaSchool of Nursing, University of Pittsburgh, Pittsburgh, PA.
Yvette P ConleySchool of Nursing, University of Pittsburgh, Pittsburgh, PA.
University of Pittsburgh · USMagee-Womens Hospital · USCancer Research And Biostatistics · USIndiana University School of MedicineUPMC Hillman Cancer Center · US

Funding

Targeting Research and Academic Training of Nurses in GenomicsT32NR009759 · NINR · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI CONLEY, YVETTE P · 2006 to 2025
$4.5M
Long Term Trajectory of Cognitive Function Related to Anastrozole Use in WomenR01CA107408 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI BENDER, CATHERINE M. · 2005 to 2015
$3.8M
Cognitive Function and Breast Cancer: Genomics and Disease CharacteristicsF31NR014590 · NINR · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI KOLECK, THERESA ANN · 2013 to 2016
$104k
NCI NIH HHS R01 CA107408NINR NIH HHS F31 NR014590NINR NIH HHS T32 NR009759
6 · The paper itself

Abstract

purposeInspired by the hypothesis that heterogeneity in the biology of breast cancers at the cellular level may account for cognitive dysfunction symptom variability in survivors, the current study explored relationships between host single-nucleotide polymorphisms (SNPs) in 25 breast cancer-related candidate genes ( PATIENTS AND

methodsThe sample (n=220) was comprised of 138 postmenopausal women newly diagnosed with early stage breast cancer and 82 postmenopausal age- and education-matched healthy controls without breast cancer. Cognitive performance was assessed after primary surgery but prior to initiation of adjuvant chemotherapy and/or hormonal therapy using a comprehensive battery of neuropsychological tests encompassing eight cognitive function composite domains: attention, concentration, executive function, mental flexibility, psychomotor speed, verbal memory, visual memory, and visual working memory. In total, 131 SNPs were included in the analysis. Standard and robust multiple linear regression modeling was used to examine relationships between each domain and the presence or absence of one or more minor alleles for each SNP. Genetic risk/protection scores (GRSs) were calculated for each domain to evaluate the collective effect of possession of multiple risk/protective alleles.

resultsWith the exception of

conclusionAssociations between host SNPs and computed GRSs and variability in pretreatment cognitive function performance support the study hypothesis, and warrant further investigations to identify biomarkers for breast cancer-related cognitive dysfunction.

Indexed as

biomarkersbreast neoplasmscognitiongenetics

Identifiers

PMID28424560
PMCPMC5344452
OpenAlexW2594091688

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.